Modified Multi-Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of DFU and VLUs

Exclusion criteria

• ✕. The potential subject is known to have a life expectancy of \< 6 months.
• ✕. The potential subject's target ulcer is not secondary to diabetes.
• ✕. The target ulcer is infected, requires systemic antibiotic therapy, or there is cellulitis in the surrounding skin.
• ✕. The target ulcer exposes tendon or bone.
• ✕. There is evidence of osteomyelitis complicating the target ulcer.
• ✕. The potential subject is receiving immunosuppressants (including systemic corticosteroids at doses greater than 10 mg of prednisone per day or equivalent) or cytotoxic chemotherapy or is taking medications that the PI believes will interfere with wound healing (e.g., biologics).
• ✕. The potential subject is taking hydroxyurea .
• ✕. The potential subject has applied topical steroids to the ulcer surface within one month of initial screening.